COPD Trial, Recruiting NCT06810323 Sponsor: University of Virginia Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06810323
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with COPD (a chronic lung disease)
  • People whose lung function test results show a specific breathing pattern, where the ratio of two measurements (FEV1/FVC) is less than 0.80 after using a bronchodilator (a medication that opens the airways)
  • People who have a prescription to use oxygen continuously at home through a nasal tube or mask
  • People who are currently in a stable state of health, with no hospital stays or flare-ups of their condition in the past 6 weeks

Who may not be able to join:

  • People whose lung function test shows that their FEV1 (a measure of how much air can be breathed out in one second) is less than 25% of the expected value after using a bronchodilator
  • People who only use oxygen occasionally at home, rather than continuously
  • People who are unable to understand simple instructions
  • People who have had a respiratory infection or a flare-up of their lung condition within the past 6 weeks (confirm with trial site, as this overlaps with an inclusion criterion and the exact distinction should be clarified)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yun M Shim, MD, Division of Pulmonary and Critical Medicine

Phone: 434-243-6074

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 January 2025
Est. completion
1 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

In lab validation study to confirm operation of the device

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov